+44 (0)1223 727114 email@example.com
Tuesday 3rd April, 2018
State-of-the-art protein detection test is helping accurately assure reprocessed surgical instruments are safe for use on patients
Tuesday 3rd April, 2018
"The best thing about having a ProReveal is that we don’t have to rely on subjective judgement calls if there are process issues because we have traceable, quantitative data to assure us that the surgical instruments we’re sending back to be used on patients are safe and fit for purpose."
Wednesday 2nd August, 2017
Adoption of the ProReveal Technology to comply with the Protein detection requirements of HTM01:01
Monday 3rd October, 2016
Synoptics appoints life science expert, Dr Brian Stammers as new CEO to develop and support the Group’s strategic direction
Wednesday 3rd August, 2016
Piedmont Atlanta Hospital, USA successfully uses ProReveal Protein Detection Test to optimize its decontamination process and maintain excellent patient safety
Monday 9th May, 2016
The following article appeared in the May 2016 edition of Clinical Services Journal.
As debate continues over the potential risks posed by prion diseases, the Department of Health has highlighted the importance of aiming for lower levels of protein contamination on surgical instruments. Strategies to improve protein detection and enhance patient safety were discussed at a recent conference, hosted by the National Performance Advisory Group.
Monday 16th November, 2015
Watch the Fluorescence Based Residual Protein Detection webinar - sponsored by Ultra Clean Systems. Facilitators - Tom Overbey, Director of Marketing at Ultra Clean, Dr David Perret, Professor of Bioanalytical Science, Barts Medical School, London and Rose Seavey, President/CEO of Seavey Healthcare Consulting LLC, USA
Thursday 27th August, 2015
Synoptics celebrates 30 years of successful international operation with many brands now global leading technologies
Thursday 25th September, 2014
Cambridge News Top Innovations Awards names ProReveal in top twenty - recognising breakthrough test for detecting residual proteins on surgical instruments is a technology to watch
Thursday 31st July, 2014
ProReveal protein detection test with process validation analytics measures effectiveness of decontamination process to help improve patient safety
Saturday 26th July, 2014
Lakeland Regional Medical Center in Florida cancels surgeries over fear of contaminated instruments
Tuesday 29th July, 2014
This is a copy of Synoptics Health's reply to Andrew Miller, Science & Technology Committee following the publication of the Science & Technology Committee Report on vCJD transmission.
Thursday 24th July, 2014
The government has developed a "casual attitude" to the human form of "mad cow disease", MPs have warned. The Science and Technology Committee said the low incidence of variant Creutzfeldt-Jakob disease (vCJD) was being "used as justification for inaction".
Wednesday 18th June, 2014
Synoptics Health appoints Ultra Clean as US distributor for ProReveal allowing US SSDs to access the world's most sensitive test for detecting residual proteins on surgical instruments
Wednesday 27th November, 2013
Serchem harnesses the power of the ProReveal protein detection test to rapidly optimise detergent chemistries to meet any decontamination regulations
Friday 15th November, 2013
ProReveal 2, a next generation test to detect protein on surgical instruments will be unveiled at Medica, Hall 1, on Synoptics Health Stand 1F11
Friday 30th August, 2013
MP to visit Synoptics Health in support of new technology to revolutionise testing of decontaminated surgical instruments
Wednesday 24th July, 2013
Major international healthcare training centre, Eastwood Park, UK will be using ProReveal, a test to detect proteins on surgical instruments, to complement training of sterile services professionals on how to assess the validity of decontamination processes.
Monday 24th June, 2013
Synoptics Health appoints six distributors in Asia-Pacific region - allowing hundreds of hospitals access to an effective protein detection test